Prevalence of cardiovascular risk factors and disease in patients with schizophrenia: baseline results from a prospective cohort study with long-term clinical follow-up
Abstract Patients with schizophrenia have excess cardiovascular risk, contributing to a reduced life expectancy of 15–20 years compared with the general population. To improve the understanding of the development and clinical trajectory of cardiovascular disease in patients with schizophrenia, we ar...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Schizophrenia |
| Online Access: | https://doi.org/10.1038/s41537-025-00642-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849342689507540992 |
|---|---|
| author | Christoffer Polcwiartek Svend Eggert Jensen Jens Brøndum Frøkjær René Ernst Nielsen |
| author_facet | Christoffer Polcwiartek Svend Eggert Jensen Jens Brøndum Frøkjær René Ernst Nielsen |
| author_sort | Christoffer Polcwiartek |
| collection | DOAJ |
| description | Abstract Patients with schizophrenia have excess cardiovascular risk, contributing to a reduced life expectancy of 15–20 years compared with the general population. To improve the understanding of the development and clinical trajectory of cardiovascular disease in patients with schizophrenia, we are conducting a prospective cohort study with comprehensive cardiovascular and psychiatric follow-up examinations every third year from baseline. In the present study, we aimed to describe and analyze the baseline results of this prospective cohort. The prospective cohort study enrolled participants with recent-onset schizophrenia (planned: n = 100), chronic schizophrenia (planned: n = 200), and controls for recent-onset patients (planned: n = 100) in the North Denmark Region from 2015–2019. We included 70 patients with recent-onset schizophrenia (mean age, 24.5 years; males, 54%; mean illness duration, 1 year), 165 patients with chronic schizophrenia (mean age, 49.5 years; males, 57%; mean illness duration, 21.1 years), and 85 controls for recent-onset patients (mean age, 24.4 years; males, 53%). At baseline, cardiovascular risk factors were highly prevalent in patients with schizophrenia (metabolic syndrome: 60%, hypercholesterolemia: 13%, diabetes: 13%, hypertension: 4%). Conversely, the prevalence of manifest cardiac disease, including heart failure, coronary artery disease, and atrial fibrillation/flutter was overall low (~1%). In conclusion, point-prevalences of cardiovascular risk factors were relatively high in patients with schizophrenia, while severe cardiac disease was less pronounced at baseline. Further prospective assessment is planned to determine and understand cardiovascular disease progression, and whether there are differences in the clinical trajectory between patients with recent-onset/chronic schizophrenia and controls over time. |
| format | Article |
| id | doaj-art-6d0a27589f04431c8478c1df39fc85ab |
| institution | Kabale University |
| issn | 2754-6993 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Schizophrenia |
| spelling | doaj-art-6d0a27589f04431c8478c1df39fc85ab2025-08-20T03:43:16ZengNature PortfolioSchizophrenia2754-69932025-07-011111610.1038/s41537-025-00642-wPrevalence of cardiovascular risk factors and disease in patients with schizophrenia: baseline results from a prospective cohort study with long-term clinical follow-upChristoffer Polcwiartek0Svend Eggert Jensen1Jens Brøndum Frøkjær2René Ernst Nielsen3Department of Cardiology, Aalborg University HospitalDepartment of Cardiology, Aalborg University HospitalDepartment of Clinical Medicine, Aalborg UniversityDepartment of Clinical Medicine, Aalborg UniversityAbstract Patients with schizophrenia have excess cardiovascular risk, contributing to a reduced life expectancy of 15–20 years compared with the general population. To improve the understanding of the development and clinical trajectory of cardiovascular disease in patients with schizophrenia, we are conducting a prospective cohort study with comprehensive cardiovascular and psychiatric follow-up examinations every third year from baseline. In the present study, we aimed to describe and analyze the baseline results of this prospective cohort. The prospective cohort study enrolled participants with recent-onset schizophrenia (planned: n = 100), chronic schizophrenia (planned: n = 200), and controls for recent-onset patients (planned: n = 100) in the North Denmark Region from 2015–2019. We included 70 patients with recent-onset schizophrenia (mean age, 24.5 years; males, 54%; mean illness duration, 1 year), 165 patients with chronic schizophrenia (mean age, 49.5 years; males, 57%; mean illness duration, 21.1 years), and 85 controls for recent-onset patients (mean age, 24.4 years; males, 53%). At baseline, cardiovascular risk factors were highly prevalent in patients with schizophrenia (metabolic syndrome: 60%, hypercholesterolemia: 13%, diabetes: 13%, hypertension: 4%). Conversely, the prevalence of manifest cardiac disease, including heart failure, coronary artery disease, and atrial fibrillation/flutter was overall low (~1%). In conclusion, point-prevalences of cardiovascular risk factors were relatively high in patients with schizophrenia, while severe cardiac disease was less pronounced at baseline. Further prospective assessment is planned to determine and understand cardiovascular disease progression, and whether there are differences in the clinical trajectory between patients with recent-onset/chronic schizophrenia and controls over time.https://doi.org/10.1038/s41537-025-00642-w |
| spellingShingle | Christoffer Polcwiartek Svend Eggert Jensen Jens Brøndum Frøkjær René Ernst Nielsen Prevalence of cardiovascular risk factors and disease in patients with schizophrenia: baseline results from a prospective cohort study with long-term clinical follow-up Schizophrenia |
| title | Prevalence of cardiovascular risk factors and disease in patients with schizophrenia: baseline results from a prospective cohort study with long-term clinical follow-up |
| title_full | Prevalence of cardiovascular risk factors and disease in patients with schizophrenia: baseline results from a prospective cohort study with long-term clinical follow-up |
| title_fullStr | Prevalence of cardiovascular risk factors and disease in patients with schizophrenia: baseline results from a prospective cohort study with long-term clinical follow-up |
| title_full_unstemmed | Prevalence of cardiovascular risk factors and disease in patients with schizophrenia: baseline results from a prospective cohort study with long-term clinical follow-up |
| title_short | Prevalence of cardiovascular risk factors and disease in patients with schizophrenia: baseline results from a prospective cohort study with long-term clinical follow-up |
| title_sort | prevalence of cardiovascular risk factors and disease in patients with schizophrenia baseline results from a prospective cohort study with long term clinical follow up |
| url | https://doi.org/10.1038/s41537-025-00642-w |
| work_keys_str_mv | AT christofferpolcwiartek prevalenceofcardiovascularriskfactorsanddiseaseinpatientswithschizophreniabaselineresultsfromaprospectivecohortstudywithlongtermclinicalfollowup AT svendeggertjensen prevalenceofcardiovascularriskfactorsanddiseaseinpatientswithschizophreniabaselineresultsfromaprospectivecohortstudywithlongtermclinicalfollowup AT jensbrøndumfrøkjær prevalenceofcardiovascularriskfactorsanddiseaseinpatientswithschizophreniabaselineresultsfromaprospectivecohortstudywithlongtermclinicalfollowup AT reneernstnielsen prevalenceofcardiovascularriskfactorsanddiseaseinpatientswithschizophreniabaselineresultsfromaprospectivecohortstudywithlongtermclinicalfollowup |